ACSL4 and melanoma: A375 melanoma cells were subsequently pretreated with iEV-NC, iEV-150, or iEV-150 combined with sh-ACSL4 or sh-CHAC1 for 48 h before being cocultured with CD8+ T cells (Figure 7G).